Form 4: Medicine Man Technologies Director Acquires Shares as Compensation
SEC Form 4 Filing
Jeffrey Cozad, a director at Medicine Man Technologies, acquired 70,513 shares of common stock as compensation for board service.
Summary
- Jeffrey Cozad, a director of Medicine Man Technologies, Inc. (SHWZ), acquired 70,513 shares of common stock on June 28, 2024.
- The shares were granted as compensation for his service on the board of directors.
- The aggregate value of the shares was $27,500, based on the closing price of the common stock on the OTCQX Best Market on June 28, 2024.
- Following the transaction, Cozad directly owns 322,131 shares of Medicine Man Technologies.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction of a director receiving stock compensation. It doesn't indicate any significant positive or negative developments for the company.
Positives
- The acquisition of shares by a director demonstrates their continued investment in the company's success.
Industry Context
This type of stock grant is a common practice for compensating board members, particularly in smaller or growth-oriented companies. It aligns the director's interests with those of the shareholders.
Comparison to Industry Standards
- Stock grants to board members are a common practice across various industries, especially in smaller companies where cash compensation might be limited.
- The size of the grant, valued at $27,500, would need to be compared to similar companies in the cannabis industry to determine if it's within the typical range.
- Companies like Canopy Growth, Aurora Cannabis, and Tilray also use stock options and grants as part of their compensation packages for directors and executives.
Stakeholder Impact
- The stock grant dilutes existing shareholders' equity slightly.
- It aligns the director's interests with those of the shareholders, potentially leading to better governance.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of transaction: Jeffrey Cozad acquired 70,513 shares of common stock. |
| 07/02/2024 | Date of signature on the Form 4 filing. |
Keywords
Medicine Man Technologies, SHWZ, Jeffrey Cozad, Director, Stock Acquisition, Form 4, Compensation, OTCQX, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.